From: The role of corticosteroids in severe community-acquired pneumonia: a systematic review
Reference | Mortality, percentage | Clinical course | Systemic inflammation | ||
---|---|---|---|---|---|
LOS, days | MODS | AB duration, days | |||
Marik, et al. [21] | 7.1 versus 18.8 (P = NS) | 4.6 versus 4.3 | N/A | N/A | Plasma TNF-α concentrations; no effect |
Confalonieri, et al. [6] | 0 versus 30 (P = 0.009) | 10 versus 18 (P = 0.01) | 0.3 versus 1.0 (P = 0.003) | N/A | Lower CRP levels at day 8 18 versus 34 mg/dL (P = 0.01) |
Mikami, et al. [20] | 6 versus 0 (P = 0.99) | 11.3 versus 15.5 (P = 0.182) | N/A | 8.5 versus 12.3 (P = 0.026) | CRP Faster normalization of CRP levels (7.6 versus 11.7 days; P = 0.02) |
Garcia-Vidal, et al. [19] | OR, 0.287; 95% CI, 0.113 to 0.732 | 7.1 versus 13.8 (P = 0.005) | N/A | N/A | N/A |